首站-论文投稿智能助手
典型文献
Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates
文献摘要:
The continuously arising of SARS-CoV-2 variants has been posting a great threat to public health safety globally,from B.1.17(Alpha),B.1.351(Beta),P.1(Gamma),B.1.617.2(Delta)to B.1.1.529(Omicron).The emerging or re-emerging of the SARS-CoV-2 variants of concern is calling for the constant monitoring of their epidemics,pathogenicity and immune escape.In this study,we aimed to characterize replication and pathogenicity of the Alpha and Delta variant strains isolated from patients infected in Laos.The amino acid mutations within the spike fragment of the isolates were determined via sequencing.The more efficient replication of the Alpha and Delta isolates was documented than the prototyped SARS-CoV-2 in Calu-3 and Caco-2 cells,while such features were not observed in Huh-7,Vero E6 and HPA-3 cells.We utilized both animal models of human ACE2(hACE2)transgenic mice and hamsters to evaluate the pathogenesis of the isolates.The Alpha and Delta can replicate well in multiple organs and cause moderate to severe lung pathology in these animals.In conclusion,the spike protein of the isolated Alpha and Delta variant strains was characterized,and the replication and pathogenicity of the strains in the cells and animal models were also evaluated.
文献关键词:
作者姓名:
Xiao-Li Feng;Dandan Yu;Mi Zhang;Xiaohong Li;Qing-Cui Zou;Wentai Ma;Jian-Bao Han;Ling Xu;Cuixian Yang;Wang Qu;Zhong-Hua Deng;Junyi Long;Yanghaopeng Long;Mingkun Li;Yong-Gang Yao;Xing-Qi Dong;Jianxiong Zeng;Ming-Hua Li
作者机构:
Kunming National High-level Biosafety Research Center for Non-Human Primates,Center for Biosafety Mega-Science,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650107,China;Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences,and KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650201,China;National Resource Center for Non-Human Primates,National Research Facility for Phenotypic&Genetic Analysis of Model Animals(Primate Facility),Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming 650107,China;Department of Infectious Diseases,Yunnan Provincial Infectious Diseases Hospital,Kunming,650301,China;Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,and China National Center for Bioinformation,Beijing,100101,China;University of Chinese Academy of Sciences,Beijing,100049,China;Center for Excellence in Animal Evolution and Genetics,Chinese Academy of Sciences,Kunming,650201,China;Kunming College of Life Science,University of Chinese Academy of Sciences,Kunming 650204,China;Yunnan Key Laboratory of Biodiversity Information,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650201,China
文献出处:
引用格式:
[1]Xiao-Li Feng;Dandan Yu;Mi Zhang;Xiaohong Li;Qing-Cui Zou;Wentai Ma;Jian-Bao Han;Ling Xu;Cuixian Yang;Wang Qu;Zhong-Hua Deng;Junyi Long;Yanghaopeng Long;Mingkun Li;Yong-Gang Yao;Xing-Qi Dong;Jianxiong Zeng;Ming-Hua Li-.Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates)[J].中国病毒学,2022(06):804-812
A类:
prototyped
B类:
Characteristics,replication,pathogenicity,SARS,CoV,Alpha,Delta,isolates,continuously,arising,variants,has,been,posting,great,threat,public,health,safety,globally,from,Beta,Gamma,Omicron,emerging,concern,calling,constant,monitoring,their,epidemics,immune,escape,In,this,study,aimed,strains,isolated,patients,infected,Laos,amino,acid,mutations,within,spike,fragment,were,determined,via,sequencing,more,efficient,was,documented,than,Calu,Caco,cells,while,such,features,not,observed,Huh,Vero,E6,HPA,We,utilized,both,models,human,hACE2,transgenic,mice,hamsters,pathogenesis,can,replicate,well,multiple,organs,cause,moderate,severe,lung,pathology,these,animals,conclusion,protein,characterized,also,evaluated
AB值:
0.562829
相似文献
CUL4B facilitates HBV replication by promoting HBx stabilization
Haixia Shan;Bo Wang;Xiaodong Zhang;Hui Song;Xi Li;Yongxin Zou;Baichun Jiang;Huili Hu;Hao Dou;Changshun Shao;Lifen Gao;Chunhong Ma;Xiaoyun Yang;Xiaohong Liang;Yaoqin Gong-Key Laboratory for Experimental Teratology of the Ministry of Education,Key Laboratory of Infection and Immunity of Shandong Province and Department of Immunology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Laboratory Diagnosis,Cangzhou Combination of Traditional Chinese and Western Medicine Hospital of Hebei Province,Cangzhou 061000,China;Division of Gastroenterology and Hepatology,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai Institute of Digestive Disease,Shanghai 200120,China;Ministry of Education Key Laboratory of Experimental Teratology and Institute of Molecular Medicine and Genetics,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong,Jinan 250012,China;Department of Gastroenterology,Qilu Hospital,Shandong University,Jinan 250012,China
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Na-Na Zhang;Rong-Rong Zhang;Yi-Fei Zhang;Kai Ji;Xiao-Chuan Xiong;Qian-Shan Qin;Peng Gao;Xi-Shan Lu;Hang-Yu Zhou;Hai-Feng Song;Bo Ying;Cheng-Feng Qin-Department of Virology,State Key Laboratory of Pathogen and Biosecurity,Beijing Institute of Microbiology and Epidemiology,Academy of Military Medical Sciences,Beijing,China;School of Medicine,Tsinghua University,Beijing,China;Kunming University of Science and Technology,Kunming,Yunnan,China;Suzhou Abogen Biosciences Co.,Ltd.,Suzhou,Jiangsu,China;School of Life Sciences,Fujian Agriculture and Forestry University,Fuzhou,Fujian,China;Institute of Systems Medicine,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,China;Research Unit of Discovery and Tracing of Natural Focus Diseases,Chinese Academy of Medical Sciences,Beijing,China
Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo
Mengjiao Li;Zi-Wei Ye;Kaiming Tang;Liang Guo;Wenwen Bi;Yuyuan Zhang;Yan-dong Tang;Guoguang Rong;Mohamad Sawan;Xin Yin;Ren Sun;Shuofeng Yuan;Bobo Dang-Fudan University,Shanghai,China;Key Laboratory of Structural Biology of Zhejiang Province,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China;Center for Infectious Disease Research,Westlake Laboratory of Life Sciences and Biomedicine,Hangzhou,Zhejiang,China;Institute of Biology,Westlake Institute for Advanced Study,Hangzhou,Zhejiang,China;Department of Microbiology,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China;State Key Laboratory of Emerging Infectious Diseases,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China;State Key Laboratory of Veterinary Biotechnology,Harbin Veterinary Research Institute,Chinese Academy of Agricultural Sciences,Harbin,China;CenBRAIN Lab.,School of Engineering,Westlake University,Hangzhou,Zhejiang,China;CenBRAIN Lab.,Westlake Institute for Advanced Study,Hangzhou,Zhejiang,China;School of Biomedical Sciences,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China
Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins
Youwei Xu;Canrong Wu;Xiaodan Cao;Chunyin Gu;Heng Liu;Mengting Jiang;Xiaoxi Wang;Qingning Yuan;Kai Wu;Jia Liu;Deyi Wang;Xianqing He;Xueping Wang;Su-Jun Deng;H.Eric Xu;Wanchao Yin-The CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;Shanghai Jemincare Pharmaceuticals Co.,Ltd.,Shanghai,China;School of Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing,Jiangsu,China;The Shanghai Advanced Electron Microscope Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;University of Chinese Academy of Sciences,Beijing,China;School of Life Science and Technology,ShanghaiTech University,Shanghai,China;Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Guangdong,China
Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants,including Omicron sublineages
Lei Wang;Wangjun Fu;Linlin Bao;Zijing Jia;Yuxia Zhang;Yunjiao Zhou;Wei Wu;Jianbo Wu;Qianqian Zhang;Yidan Gao;Kang Wang;Qiao Wang;Chuan Qin;Xiangxi Wang-CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing,China;University of Chinese Academy of Sciences,Beijing,China;Key Laboratory of Human Disease Comparative Medicine,Chinese Ministry of Health,Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences and Comparative Medicine Center,Peking Union Medical College,Beijing,China;Changping Laboratory,Beijing,China;Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),Shanghai Institute of Infectious Disease and Biosecurity,Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Xiaoqiang Liu;Yuhua Li;Zhongfang Wang;Shouchun Cao;Weijin Huang;Lin Yuan;Yi-Jiao Huang;Yan Zheng;Jingjing Chen;Bo Ying;Zuoyun Xiang;Jin Shi;Jincun Zhao;Zhen Huang;Cheng-Feng Qin-Yunnan Province Centre for Disease Control and Prevention,Kunming,Yunnan,China;National Institutes for Food and Drug Control,Beijing,China;Respiratory Medicine,Guangzhou Institute of Respiratory Health,Guangzhou,Guangdong,China;Walvax Biotechnology Co.,Ltd.,Kunming,Yunnan,China;State Key Laboratory of Pathogen and Biosecurity,Beijing Institute of Microbiology and Epidemiology,Academy of Military Medical Sciences,Beijing,China;Suzhou Abogen Biosciences Co.,Ltd,Suzhou,Jiangsu,China;Research Unit of Discovery and Tracing of Natural Focus Diseases,Chinese Academy of Medical Sciences,Beijing,China
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Huan Ma;Xinghai Zhang;Peiyi Zheng;Peter H.Dube;Weihong Zeng;Shaohong Chen;Qingyu Cheng;Yunru Yang;Yan Wu;Junhui Zhou;Xiaowen Hu;Yan Xiang;Huajun Zhang;Sandra Chiu;Tengchuan Jin-Department of Pulmonary and Critical Care Medicine,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,Hubei,China;Laboratory of Structural Immunology,CAS Key Laboratory of Innate Immunity and Chronic Disease,Hefei National Laboratory for Physical Sciences at Microscale,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;Department of Microbiology,Immunology and Molecular Genetics,University of Texas Health Science Center at San Antonio,San Antonio,TX,USA;University of Chinese Academy of Sciences,Beijing,China;Institute of Health and Medicine,Hefei Comprehensive National Science Center,Hefei,Anhui,China
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang;Ying Lu;Yan-Bo Zhao;Fan Shen;Chang-Fa Fan;Qian Wang;Wen-Qiang He;Xiao-Yan He;Ze-Kai Li;Tao-Tao Chen;Cui-Xian Yang;You-Zhi Li;Si-Xuan Xiao;Zu-Jiang Zhao;Xu-Sheng Huang;Rong-Hua Luo;Liu-Meng Yang;Mi Zhang;Xing-Qi Dong;Ming-Hua Li;Xiao-Li Feng;Qing-Cui Zhou;Wang Qu;Shibo Jiang;Songying Ouyang;Yong-Tang Zheng-Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province,KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,Yunnan,China;University of the Chinese Academy of Sciences,Beijing,China;The Key Laboratory of Innate Immune Biology of Fujian Province,Provincial University Key Laboratory of Cellular Stress Response and Metabolic Regulation,Biomedical Research Center of South China,Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education,College of Life Sciences,Fujian Normal University,Fuzhou,Fujian,China;Division of Animal Model Research,Institute for Laboratory Animal Resources,National Institutes for Food and Drug Control,Beijing,China;Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),Shanghai Institute of Infectious Disease and Biosecurity,School of Basic Medical Sciences,Fudan University,Shanghai,China;Yunnan Provincial Infectious Disease Hospital,Kunming,Yunnan,China;Kunming National High-level Biosafety Research Center for Non-human Primates,Center for Biosafety Mega-Science,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,Yunnan,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。